A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Recruiting · NCT07219589 · Registry updated 2026-05-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-05-04 | NCT07219589 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hanmi Pharmaceutical Company Limited | 15 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medpace Clinical Pharmacology Unit | Cincinnati | United States | 3 |